Glomerular hyperfiltration

M Cortinovis, N Perico, P Ruggenenti… - Nature reviews …, 2022 - nature.com
Circulating blood is filtered across the glomerular barrier to form an ultrafiltrate of plasma in
the Bowman's space. The volume of glomerular filtration adjusted by time is defined as the …

Autosomal dominant polycystic kidney disease

VE Torres, PC Harris, Y Pirson - The Lancet, 2007 - thelancet.com
Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal,
monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which …

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials

MV Irazabal, LJ Rangel, EJ Bergstralh… - Journal of the …, 2015 - journals.lww.com
The rate of renal disease progression varies widely among patients with autosomal
dominant polycystic kidney disease (ADPKD), necessitating optimal patient selection for …

A new equation to estimate glomerular filtration rate

AS Levey, LA Stevens, CH Schmid… - Annals of internal …, 2009 - acpjournals.org
Background: Equations to estimate glomerular filtration rate (GFR) are routinely used to
assess kidney function. Current equations have limited precision and systematically …

[HTML][HTML] Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities

LA Stevens, MA Claybon, CH Schmid, J Chen… - Kidney international, 2011 - Elsevier
An equation from the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
provides more accurate estimates of the glomerular filtration rate (eGFR) than that from the …

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

JJ Bissler, FX McCormack, LR Young… - … England Journal of …, 2008 - Mass Medical Soc
Background Angiomyolipomas in patients with the tuberous sclerosis complex or sporadic
lymphangioleiomyomatosis are associated with mutations in tuberous sclerosis genes …

Everolimus in patients with autosomal dominant polycystic kidney disease

G Walz, K Budde, M Mannaa… - … England Journal of …, 2010 - Mass Medical Soc
Background Autosomal dominant polycystic kidney disease (ADPKD) is a slowly
progressive hereditary disorder that usually leads to end-stage renal disease. Although the …

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

AL Serra, D Poster, AD Kistler, F Krauer… - … England Journal of …, 2010 - Mass Medical Soc
Background In autosomal dominant polycystic kidney disease (ADPKD), aberrant activation
of the mammalian target of rapamycin (mTOR) pathway is associated with progressive …

Autosomal dominant polycystic kidney disease

PA Gabow - New England Journal of Medicine, 1993 - Mass Medical Soc
Autosomal dominant polycystic kidney disease is one of the most common hereditary
disorders, being 10 times more common than sickle cell disease, 15 times more common …

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease

AB Chapman, JE Bost, VE Torres… - Clinical Journal of the …, 2012 - journals.lww.com
Results After a mean follow-up of 7.9 years, stage 3 CKD was attained in 30.7% of the
enrollees. Using baseline htTKV, negative correlations with GFR increased from− 0.22 at …